Related Experiment Video

Updated: Apr 29, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

20.5K

[Multidisciplinary treatment of glioblastoma]

N Barthelemy, C Gennigens, F Scholtes

    Revue Medicale De Liege
    |May 15, 2014
    PubMed

    Abstract:

    Glioblastoma is a primary brain tumor that occurs most often in elderly patients. Despite improved management, the prognosis of this cancer remains poor. This review describes the multidisciplinary management of the patient with glioblastoma. It includes surgery, radiation therapy and chemotherapy.

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    29.3K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    3.3K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    08:00

    The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

    Published on: April 16, 2019

    20.5K
    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    29.3K
    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
    07:25

    Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

    Published on: March 1, 2024

    3.3K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    2.6K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    2.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    Molecular profiling and access to treatment for rare cancers in Europe.

    Nature communications·2026

    Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024

    Measurement of polarization observables , , and in and photoproduction off quasi-free nucleons.

    The European physical journal. A, Hadrons and nuclei·2023

    Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer.

    Gynecologic oncology·2023

    A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms.

    AJNR. American journal of neuroradiology·2023

    Recurrent or primary metastatic cervical cancer: current and future treatments.

    ESMO open·2022

    [Retinal intoxication with tamoxifen treatment for breast cancer].

    Revue medicale de Liege·2026

    [Volontary poisoning with yew ( Taxus baccata) : a fatal case].

    Revue medicale de Liege·2026

    [Pseudotumor on metal debris after total hip arthroplasty].

    Revue medicale de Liege·2026

    [Management of post-traumatic tibiotalar osteoarthritis following a failed osteosynthesis : retrograde plantar nailing].

    Revue medicale de Liege·2026

    [Femoral neck stress fracture in a young female runner].

    Revue medicale de Liege·2026

    [Arthroscopy of the hip : modern times surgery].

    Revue medicale de Liege·2026

    Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer Patients.

    The oncologist·2026

    A phase II multi-institutional single arm trial evaluating TG4010 vaccine plus nivolumab in non-small cell lung cancer.

    Oncoimmunology·2026

    Intravesical gemcitabine versus Bacillus Calmette-Guérin (BCG) for intermediate-/high-risk non-muscle-invasive bladder cancer during the BCG shortage: Safety, efficacy, and health-economic context.

    Investigative and clinical urology·2026

    Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.

    Korean journal of radiology·2026

    Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026

    Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.

    Transfusion medicine (Oxford, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us